image 8
image 1
image 5
image 6
image 4
image 3
image 2
image 7

The Rappaport Institute looks forward to continuing to make substantial future contributions in biomedical research"

Professor Karl Skorecki

Technologies

Disease AreasBiopharmaceuticalMedical DevicesMedical DiagnosticsPersonalized TechnologiesBio Research ToolsOthers
 
Home » About Us » Board of Directors » Ruth Alon

Ms. Ruth Alon

Position:Director

Ruti Alon joined Pitango in 1997. With over 30 years of international experience in the high-tech medical industry and heads the life sciences activities at Pitango.

Ruti previously worked on Wall Street where she held senior positions with Montgomery Securities and Kidder Peabody & Co as a senior medical device analyst.

Ruti was the founder and Chairperson of ILSI, an umbrella organization representing approximately 750 Israeli life sciences companies. Currently, she sits on the Board of IATI – Israel Advanced Technologies Industry - an organization presenting the Israeli high-tech industry, created via a merger of ILSI with HTIA.

Ruti previously served on the Boards of ColBar, acquired by Johnson& Johnson, Disc-O-Tech acquired by Kyphon and Ventor acquired by Medtronic (NYSE: MDT)

She is currently is the Chairperson of the Boards of BioControl and BrainsGate. In addition, she is a member of the Boards of numerous Pitango portfolio companies including, BetaO2, HealOr, Vascular Biogenics (VBL), AposTherapy and CarboFix.

Haptoglobin Typing

Report an Invention

For BioRap InventorsFunding Opportunities

Rappaport Institute

The Rappaport InstituteNobel Prize
Copyright © 2014 BioRap Technologies LTD. All Rights Reserved. Created by Catom web design